National Peroxide Board of Directors

Get the latest insights into the leadership at National Peroxide. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Ness Nusli Wadia Chairman
Ms. Parvathi Menon Ind. Non-Executive Director
Mr. Jaivir Singh Ind. Non-Executive Director
Mr. Rajiv Arora Director & CEO
Dr.(Ms.) Minnie Bodhanwala Non Exe.Non Ind.Director
Mr. Viraf Mehta Ind. Non-Executive Director

National Peroxide Share price

NPL

421.3

24.00 (6.04%)
Last updated on 27 Feb, 2026 | 15:40 IST
Today's High

446.00

Today's Low

398.20

52 Week Low

376.00

52 Week High

770.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

National Peroxide FAQs

The board at National Peroxide consists of experienced professionals, including Mr. Ness Nusli Wadia , Ms. Parvathi Menon , and others, overseeing the company’s strategic and corporate governance.

Directors at National Peroxide are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Ness Nusli Wadia is the current chairman at National Peroxide.

Executive directors at National Peroxide are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, National Peroxide adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At National Peroxide, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost